Vulnerability in Oracle Corporation Siebel Life Sciences

CVE-2026-101451

Vulnerability in the Siebel Life Sciences product of Oracle Siebel CRM (component: Web UI). Supported versions that are affected are 17.0-26.9. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Siebel Life Sciences. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Siebel Life Sciences, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Siebel Life Sciences accessible data as well as unauthorized access to critical data or complete access to all Siebel Life Sciences accessible data. CVSS 3.1 Base Score 8.7 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N).

Published · last modified .

CVSS v3 metric

CVSS v3 base score 8.7 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N.

EPSS exploit prediction

No EPSS score from FIRST.org yet. New CVEs usually get one within a few days; no score means no signal yet, not low risk. How EPSS works.

Affected products

References

Frequently asked questions

What is CVE-2026-101451?
CVE-2026-101451 is a high-severity vulnerability in Oracle Corporation Siebel Life Sciences. CVSS score: 8.7/10. Published 2026-10-20.
How severe is CVE-2026-101451?
High severity. CVSS v3 base score is 8.7 out of 10.